The present disclosure relates in general to a fluorescence imaging apparatus, and more particularly, to an integration of optical coherence tomography (OCT) and fluorescence spectroscopy.
Optical coherence tomography (OCT) provides high-resolution, cross-sectional imaging of tissue microstructure in situ and in real-time, while fluorescence imaging enables visualization of molecular processes. The integration of OCT and fluorescence imaging in a single catheter provides the capability to simultaneously obtain co-localized anatomical and molecular information from a tissue such as the artery wall. For example, in “Ex. Vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm” (Biomed Opt Express 2015, 6(4): 1363-1375), Wang discloses an OCT-fluorescence imaging system using He:Ne excitation light for fluorescence and swept laser for OCT simultaneously through the optical fiber probe. Usually, in optical imaging, the signal strength can depend on the distance. The fluorescence signal is weaker when the distance from the imaging probe to the sample is farther. The system disclosed by Wang calibrates the fluorescence light intensity detected by an optical fiber using distance between the optical fiber and the tissue, while OCT can measure the distance. However, it is found that the collection efficiency of fluorescence by an optical fiber depends not only the distance between the optical fiber and the tissue, but also an optical property such as optical attenuation property or scattering property of tissue.
The present patent application aims to improve the accuracy of the fluorescence imaging by a fluorescence calibration method that incorporates the optical property of the fluorescence sample. In one embodiment, an excitation light is provided and incident on an object through an optical probe. The fluorescence light generated from the object is detected. Structural data of the object is acquired. An optical attenuation property of the object is calculated based on the structural data. The fluorescence intensity is then calibrated based on the optical attenuation property.
Preferably, a distance between optical probe and the object is also calculated and the fluorescence intensity is calibrated based on the distance and the optical attenuation property. Preferably but optionally, the fluorescence intensity and the structural data are obtained simultaneously. The fluorescence light and the structural data may be delivered by a double clad fiber, such that the structural data is delivered by a core of the double clad fiber, and the fluorescence light is delivered by a cladding of the double clad fiber. The fluorescence light may include a near-infrared light. The method of fluorescence calibration may further comprise acquiring the structural data by optical coherence tomography. The optical attenuation property includes attenuation coefficient of an OCT image. The fluorescence intensity is then calibrated and fluorescence image is constructed. In another embodiment, a method of fluorescence calibration further includes the steps of; calculating an optical attenuation property of at least the top layer of the object if the object has heterogeneous optical property, calculating the depth of at least the top layer. The fluorescence intensity is then calibrated based on the distance, optical attenuation property and the depth. Then fluorescence image is constructed.
In another embodiment, a method of fluorescence calibration including the following steps is provided. An excitation light is provided and incident on an object through an optical probe. The fluorescence intensity of the fluorescence light generated from the object is detected. Structural data of the object is acquired. A distance between the optical probe and the object is calculated. The fluorescence intensity is calibrated based on the distance. If the fluorescence intensity calibrated based on the distance is higher than a predetermined level, an optical attenuation property of the object is acquired based on the structural data. The fluorescence intensity of the fluorescence light is further calibrated based on the optical attenuation property. In another embodiment, an optical attenuation property of the object is acquired based on the structural data and the fluorescence intensity of the fluorescence light is calibrated based on the optical attenuation property. If the fluorescence intensity calibrated based on the optical attenuation property is higher than a predetermined level, a distance between the optical probe and the object is calculated. The fluorescence intensity of the fluorescence light is further calibrated based on the distance.
The method may further comprise obtaining the fluorescence intensity and the structural data simultaneously. The fluorescence light and the structural data may be delivered by a double clad fiber. The structural data is delivered by a core of the double clad fiber, and the fluorescence light is delivered by a cladding of the double clad fiber. The fluorescence light includes a near-infrared light. The method may further comprise acquiring the structural data by optical coherence tomography (OCT). The optical attenuation property includes attenuation coefficient of an OCT signal in the object. The calibrated fluorescence is then applied for correcting a fluorescence image constructed by the fluorescence light.
If the fluorescence intensity calibrated by the first calibration factor is not higher than the predetermined level, only the fluorescence intensity calibrated by the first calibration factor is applied for correcting a fluorescence image constructed by the fluorescence light. If the fluorescence intensity calibrated by the first calibration factor is higher than the predetermined level, the fluorescence intensity further calibrated by the second calibration factor is applied for correcting a fluorescence image constructed by the fluorescence light. For calibrating the fluorescence intensity using both the first and the second calibration factor, the second calibration factor can be applied to the fluorescence intensity calibrated with the first calibration factor or the third calibration factor that is calculated from the first and the second calibration factor can be applied to the original fluorescence intensity.
A fluorescence imaging system is also provided. The system includes a light source configured to generate an excitation light, an optical waveguide to guide the excitation light toward an object and to detect fluorescence light generated by the object in response to the excitation light, an OCT system configured to obtain an OCT image from the object, and a signal processor. The signal processor comprises an OCT image processing unit and a fluorescence processing unit. The OCT image processing unit is configured to calculate a distance between the catheter and the object and a attenuation coefficient. The fluorescence processing unit is configured to i) calibrate fluorescence intensity of the fluorescence light based on the distance and the attenuation coefficient; or ii) calibrate fluorescence intensity of the fluorescence light based on the distance, and if the fluorescence intensity calibrated based on the distance is higher than a predetermined level, calibrate the fluorescence light based on the attenuation coefficient.
The distal end of the optical waveguide may be configured to direct light to and collect light from a side angle. The system may further comprise a rotation unit that rotates the optical waveguide.
The system may further comprise a pullback unit for scanning the sample during the imaging. A double clad fiber may be used for delivering the fluorescence light and OCT image. The fluorescence light can be delivered by a cladding of the double clad fiber and the OCT image can be delivered by a core of the double clad fiber.
The subject disclosure further teaches a method for correcting fluorescence data measurements, comprising: defining a border between a first layer and a second layer of a subject structure; calculating a depth of the second layer; calculating a depth calibration factor by plugging in a depth value to the predetermined correction function; and correcting a fluorescence intensity by multiplying the depth correction factor.
In addition, the disclosure provides a method for correcting fluorescence data measurements, comprising: defining a border between a first layer and a second layer of a subject structure; calculating a depth of the second layer; calculating a depth calibration factor by plugging in a depth value to the predetermined correction table; and correcting a fluorescence intensity by multiplying the depth correction factor.
In yet additional embodiment, the subject method further comprises acquiring the fluorescence data and a structural data simultaneously.
In additional embodiments, the method further corrects the fluorescence data based on the distance between an optical probe and the structure prior to correcting the fluorescence data with depth calibration factor.
It is further contemplated that the method teaches the correction function being a function of depth of the fluorescence layer and an optical attenuation property of the first layer.
In yet additional embodiment, the method includes the border of the first and the second layer being defined by an automated algorithm. As well as, the border of the first and the second layer being provided by user input.
In further embodiments, the method teaches further displaying the corrected fluorescence data, wherein the fluorescence signal includes a near-infrared light, and/or is endogeneous fluorescence.
In further embodiments of the method, the fluorescence signal is emitted by an exogeneous fluorescence agent.
Furthermore, the structural data and fluorescence data are both acquired using a single catheter. In addition, the structural data may be delivered by a core of a double clad fiber and the fluorescence data may be delivered by a cladding of the double clad fiber.
The following description is of certain illustrative embodiments, although other embodiments may include alternatives, equivalents, and modifications. Additionally, the illustrative embodiments may include several novel features, and a particular feature may not be essential to practice the devices, systems, and methods described herein.
The system includes a coupler 320 in which the OCT light from the OCT light source 300 and the OCT light reflected from the sample 400 are coupled to generate interference patterns. The interference patters detected by a detector 322 such as a photodiode or multi-array camera and delivered to a processor such as a computer 100 through a data acquisition device 324. Simultaneously, the fluorescence light from the sample 400 is detected by a detector 326. The detector 326 records the fluorescence signal of the fluorescence light and delivers the fluorescence signal to the computer 100 via the data acquisition device 328. Preferably, the OCT interference patterns of the OCT lights and the fluorescence signal are delivered to the computer 100 simultaneously.
As shown in
As shown in
In one embodiment, a predetermined calibration factor table for variable distance and attenuation coefficient can be used instead of the predetermined calibration function. The distance d(p, θ) and the optical attenuation property s(p, θ) are calculated from the OCT image and the calibration factor for the closest d(p, θ) and s(p, θ) values are looked up from the calibration factor table. By multiplying the selected calibration factor to the fluorescence signal, fluorescence calibration can be performed.
As discussed above, the optical attenuation property of the fluorescence object is calculated using OCT intensity profile, that is, A-line. A total attenuation coefficient μt is the summation of an absorption coefficient, μa, and a scattering coefficient, μs. Because the absorption coefficient μa is much smaller than the scattering coefficient μs at the wavelength of the OCT light, for example, 1.3 μm, the total attenuation coefficient μt is approximately the same as the scattering coefficient as, that is, μt≈μs. The attenuation coefficient can be extracted by fitting the compounded OCT A-line into a single scattering model, which is based on Beer-Lambert law, and accounts for the confocal point spread function property of sample arm optics. For example, fitting may be carried out by using least square fitting with the logcompressed A-line data. The maximum intensity point close to the lumen boundary may be used at the starting point for the line fitting. Adjacent A-line data may be averaged to reduce the noise.
The calibration function can be predetermined by measuring fluorescence intensity of phantoms with different optical properties as a function of distance between the optical probe (catheter) and the fluorescence object. To obtain the phantoms with various optical attenuation properties, phantoms containing scattering particles such as intralipid can be prepared and used. The attenuation coefficient of the phantoms can be measured by imaging phantoms with OCT and calculating the attenuation coefficient as described. Using multiple fluorescent phantoms with different optical properties, the fluorescence intensity profile as a function of distance for each optical property can be obtained. Based on the measurement, fitting model ƒ(x, y) as a function of distance (x) and attenuation coefficient (y) can be obtained. The calibration function for fluorescence intensity can be obtained as g(x, y)=1/ƒ(x, y). The calibration of the fluorescence signal is achieved by multiplying the calibration factor that is obtained by plugging in the distance (x) and attenuation coefficient (y) that corresponds to the each element of the fluorescence dataset.
The calibration function ƒ(x, y) can also be prepared as the set of the calibration function of distance (x) for representative attenuation coefficient values which the fluorescence object may show. Based on the measurement, fitting model ƒ(x) as a function of distance (x) for different optical properties can be obtained. The calibration function for the fluorescence intensity is obtained as g(x)=1/ƒ(x). The calibration function g(x, y) can be obtained by selecting the calibration function closest to the sample attenuation coefficient value.
In one of the embodiments of the present disclosure, to each of the curves obtained from different phantoms an exponential model ƒ(x)=a*exp(b*x)+c*exp(d*x) can be applied for fitting. The constants (a) through (d) are determined in the fitting process. Also, each of the phantoms has a known attenuation property. Based on the known attenuation properties associated with the known curves, the computer 100 can determine a curve for a tissue which has a specific attenuation property by interpolation or extrapolation. In this embodiment, curve measurement are performed for multiple phantoms having specific attenuation properties (A1, A2, . . . An; Ai≤Ai+1, 1<i≤n), curve fitting are performed for each measured curves and curve parameters are obtained (C1, C2, . . . , Cn; Ci=(ai, bi, ci, di), 1<i≤n). These pieces of data are stored in a memory of the computer 100. In a case where tissue imaging is performed in-vivo, the system calculates the attenuation property Ax of the tissue. The computer 100 then selects known neighboring attenuation properties Aj, Aj+1 (Aj<Ax<Aj+1) and corresponding curve parameters Cj, Cj+1. By interpolation, the computer 100 can obtain a set of curve parameters Cx=(ax, bx, cx, dx), and by using the curve parameters and the exponential model, the computer 100 can perform distance correction.
The phantom 1104a has an inner region of which the cross-section is substantially circular and the diameter of the circle is greater along the l axis. The phantom 1104a is made of a material having a specific attenuation property Aa, and emits fluorescence light in response to excitation light emitted from the tip of the catheter. In
The imaging of the phantoms 1104a to 1104d and the following correction data acquisition processes including curve fitting processes may be done in a factory. In this case the catheter or the rest of the OCT-fluorescence imaging system is not the one that is used for the actual in-vivo imaging in the hospital. One catheter of a specific type or one OCT-fluorescence imaging system of a specific type is used to determine the correction data acquisition processes, the data is stored in a memory of a computer 100 of the OCT-fluorescence imaging system of the same specific type, to be sold to a customer.
In another embodiment, the correction data acquired in the factory is stored in a separate computer readable medium bundled with a OCT-fluorescence imaging system of the same specific type, to be sold to a customer. In yet another embodiment, the correction data acquired in a factory is associated with a specific type of a catheter and/or specific type of a OCT-fluorescence imaging system, and stored in a server accessible by customers. In this case the computer 100 at customer's site obtains the correction data from the server, by sending information of the specific type of the catheter or the OCT-fluorescence imaging system. Alternatively, correction data may be in a computer readable medium.
In in-vivo imaging, fluorescence layers in a blood vessel have a relatively higher attenuation property, whereas non-fluorescence layers in a blood vessel have a relatively lower attenuation property. But for the artificially manufactured phantoms, it is possible that a phantom made of fluorescence material having a lower attenuation property is manufactured. The distance correction function is dependent on the attenuation property of the first layer (from the inner surface) of the vessel, and it does not matter if the first layer is a fluorescence layer or a non-fluorescence layer. Therefore, the set of calibration curves obtained from imaging of the phantoms 1104a to 1104d can be used for the distance correction, in a situation that the first layer is a non-fluorescence layer and the second layer below the first layer is a fluorescence layer. This will be described in greater detail with reference to
In above described embodiments, the method of determining a distance correction curve based on the attenuation property of the tissue of the vessel emitting fluorescence. These methods can be applied to the vessel having a fluorescence layer (tissue) on the surface of the vessel. But there are some situations in which fluorescence layer is not at the surface of the vessel, and non-fluorescence layer is on top of the fluorescence layer. In this situation, depth of the non-fluorescence layer on top of the fluorescence layer is considered and distance correction (or depth correction) is performed for the non-fluorescence layer. These methods according to embodiments of the present disclosure are described below.
The material 1204a of the phantom defines an inner region of which the cross-section is substantially circular, and the diameter of the circle is constant as D, along the l axis. The material 1204a is made of a material having a specific attenuation property Aa′, and does not emit fluorescence light in response to excitation light emitted from the tip of the catheter 1201. In a plane perpendicular to the l axis, the material 1204a has a ring-shape cross-section with a width d2. The width d2 becomes monotonically larger along the l axis. The material 1205 does emit fluorescence light in response to excitation light emitted from the catheter 1201. In a plane perpendicular to the l axis, the material 1205 has a ring-shape cross-section surrounding the inner ring defined by the material 1204a. The width the ring defined by the material 1205 may be smaller along the l axis but the width and shape can be different as long as the material 1205 surrounds the material 1204a. The material 1204a and material 1205 are fixed with each other, so as to form one cylindrical phantom.
In
While the imaging is performed, the inner region of the phantom is filled with a contrast agent, which is the same contrast agent to be injected into a human vessel to be imaged by the OCT-fluorescence imaging system. By OCT and fluorescence imaging of these four cylindrical phantoms, the computer 100 obtains OCT data and fluorescence data.
Now the four correction curves fdepth_a′(x), fdepth_b′(x), fdepth_c′(x), fdepth_d′(x), or the 4 correction functions gdepth_a′(x), gdepth_b′(x), gdepth_c′(x), gdepth_d′(x), are obtained through the above described processes. These correction functions gdepth_a′(x), gdepth_b′(x), gdepth_c′(x), gdepth_d′(x) are associated with attenuation properties Aa′, Ab′, Ac′, and Ad′, respectively. By applying interpolation or extrapolation methods, the computer 100 can obtain a specific correction function gdepth_t(x) for a specific tissue having an attenuation property At, if the At is close to or in a range of {Min(Aa′, Ab′, Ac′, Ad′), Max(Aa′, Ab′, Ac′, Ad′)}. For example, if the attenuation property At meets the following condition, Ab′<At<Ac′, the system performs interpolation using gdepth_b′(x) and gdepth_c′(x) (or, fdepth_b′(x), fdepth_c′(x)) to obtain the correction function gdepth_t(x) for the specific tissue.
In step S1405 of
The determination can be made based on the fluorescence data. If there is no or little fluorescence intensity acquired by the catheter, the computer determines that the there is no fluorescence layer existed in the imaged vessel. If there is fluorescence data whose intensity is larger than a certain threshold, the computer determines that the fluorescence layer exists in the imaged vessel. By using this method, the computer also obtain where in the imaged vessel in the longitudinal direction the fluorescence layer exists, but if there are multiple layers stacked in a depth or radial direction, the computer cannot identify which of the multiple layers a fluorescence layer is. In other to identify which layer is a fluorescence layer, the computer applies a different method as shown above by using attenuation properties of the layers. But by this method of using fluorescence intensity instead of the calculated attenuation properties, the computer can easily determines if there is any fluorescence layer in the imaged vessel. In this case, step S1405 can be performed before step S1404, so that the computer can skip step S1404 and proceed to steps S1406 through S1409, which reduces processing time for imaging to displaying of the image.
In yet another embodiment, the computer utilizes both methods of (1) using the attenuation property and (2) using the fluorescence intensity. In one embodiment, the result of either (1) or (2) indicates that there is a fluorescence layer, the computer determines that the fluorescence layer exists. This method contributes to display as much fluorescence data as possible. In another embodiment, the results of both (1) and (2) indicate that there is a fluorescence layer in the imaged vessel, the computer determines that the fluorescence layer exists. This method contributes to improving liability of the fluorescence data displayed with the OCT image data.
If the computer determines that fluorescence layer exists, the process proceeds to S1406; if not, the process proceeds to S1413. In step S1413 the computer causes the display to display the OCT image data, without displaying fluorescence data, because it is determined that the fluorescence layer does not exist in the imaged vessel.
In step S1406, the computer identifies the segmented layer as a fluorescence layer or a non-fluorescence layer, based on the attenuation property.
The attenuation property of the first layer (S1) and the second layer (S2) are calculated using OCT intensity profiles. OCT intensity profiles can be obtained by averaging the adjacent A-line intensity profiles from the coordinates of the lumen (A1) and the border between the top layer and the second fluorescence layer (A2). The attenuation coefficient can be estimated by fitting the averaged OCT A-line intensity profiles into a single scattering model. The attenuation coefficient is estimated by least square fitting of the log-compressed averaged A-line intensity profiles with a linear model.
Depth correction can be applied to the second layer. In one embodiment, depth correction is applied only when the attenuation coefficient of the second layer is higher than the first layer, which implies advanced plaque tissue characteristics in the second layer such as necrotic core or macrophage infiltration.
In one variant, step S1406 can be performed after the steps S1407 and S1408 for distance correction.
In step S1407, the computer obtains distance correction data and can perform (1) a conventional distance correction method using a single correction function defined independently from the characteristics (attenuation property) of a top layer in the vessel; or (2) a distance correction method using a correction function dependent on the characteristics of a top layer in the vessel. The user can select which of the options (1) and (2) is applied to the fluorescence data. This will be described later with reference to
Where the option (1) is applied, the computer obtains a distance correction function from its memory. In a case where the option (2) is applied, the computer obtains a distance correction function based on the g(x,y) as described with reference to
In step S1408, the computer applies distance correction to the fluorescence data based on the obtained distance correction function (data). In step S1409, the computer determines if a non-fluorescence layer exists on top of the fluorescence layer. This determination can be made based on the results of the step 1407. If it is determined that the non-fluorescence layer exists, the process proceeds to step S1410 to perform depth correction of the top layer. If it is determined that the non-fluorescence layer does not exists, the process proceeds to step S1412.
In step S1410, the computer obtains depth correction data gdepth_t(x) based on the attenuation property and the correction functions gdepth_a′(x) through gdepth_d′(x) which can be generated by the methods described with reference to
In step S1412, the computer causes the display to display the OCT image data and the corrected fluorescence data which is registered with the OCT image data.
In option (1), where there is a non-fluorescence layer on top of the fluorescence layer, the distance correction is performed by using the single function, and the depth correction is performed based on the correction function determined by the attenuation property of the top layer of the vessel wall.
In option (1), where there is a fluorescence layer on top, the distance correction is performed by using the single function, and the depth correction is not applied.
In option (1), where there are non-fluorescence layers only, the distance correction or the depth correction is not applied.
In option (1), where there is a fluorescence layer only, the distance correction is performed by using the single function, and the depth correction is not applied.
In option (1), where there is a non-fluorescence layer only, the distance correction or the depth correction is not applied.
In option (2), where there is a non-fluorescence layer on top of the fluorescence layer, the distance correction is performed based on the correction function determined by the attenuation property of the top layer of the vessel wall, and the depth correction is performed based on the correction function determined by the attenuation property of the top layer of the vessel wall.
In option (2), where there is a fluorescence layer on top, the distance correction is performed based on the correction function determined by the attenuation property of the top layer of the vessel wall, and the depth correction is not applied.
In option (2), where there are non-fluorescence layers only, the distance correction or the depth correction is not applied.
In option (2), where there is a fluorescence layer only, the distance correction is performed based on the correction function determined by the attenuation property of the top layer of the vessel wall, and the depth correction is not applied.
In option (2), where there is a non-fluorescence layer only, the distance correction or the depth correction is not applied.
The depth correction in one of the embodiments of the present disclosure is basically a distance correction for the top non-fluorescence layer of the vessel. In both depth correction and distance correction, the distance correction coefficient g(x) or the depth correction function gdepth(x) is multiplied with the fluorescence intensity. Accordingly, the order of these corrections are interchangeable.
In another embodiment, a predetermined correction factor table for varying depth can be used instead of the predetermined correction function. In this case, the d(p, θ) is calculated from the OCT image and the correction factor for the closest d(p, θ) value is looked up from the correction factor table. By multiplying the selected calibration factor to the fluorescence value, fluorescence correction may be carried out.
The depth correction function can be predetermined by measuring fluorescence intensity of phantoms with a varying depth of fluorescence layer from the surface. To obtain the phantoms with varying depth, phantoms containing scattering particles, such as intralipid or TiO2, as the top layer with various thickness and the second layer that contains fluorescence material, such as fluorescence dye or quantum dot, as well as scattering particles such as intralipid or TiO2. By measuring multiple spots with varying depth, the fluorescence signal as a function of the depth of fluorescence layer is obtained. The fluorescence intensity profile as a function of depth is obtained. If the distance to the first layer from the optical probe is not uniform, distance correction may be performed. Based on the plot of the measurement, fitting model ƒdepth(x) as a function of depth (x) can be obtained. For example, exponential model such as f(x)=a*exp(b*x)+c*exp(d*x) may be used to achieve smaller fitting error; then the correction function for fluorescence intensity is obtained as gdepth(x)=1/ƒ(x).
Segmentation of the lumen and the border between the top layer and the second fluorescence layer can be processed automatically by the software algorithm. At the frame of interest for correcting fluorescence, edge detection provides the coordinates of the lumen and the border between the top layer and the second fluorescence layer.
In another embodiment, the border between the top layer and the second fluorescence layer can be defined semi-automatically by first segmentation performed by the software and further adjustment of the segmentation contour based on user input.
In another embodiment, the border between the top layer and the second fluorescence layer can be defined manually using user input to define the border contour. The depth is calculated from the coordinates of the lumen and the border.
In yet another embodiment, fluorescence intensity is first corrected for the distance from optical probe to the luminal surface, then further corrected for the fluorescence intensity for the depth of the fluorescence layer.
By imputing the depth value to the predetermined correction function, depth correction factor is determined. Distance corrected fluorescence data is depth-corrected by multiplying depth correction factor. In addition, since attenuation coefficient of the first layer over the fluorescence component may affect the fluorescence attenuation profile, attenuation coefficient can be used as a part of the correction algorithm in another embodiment.
A test phantom (Ph2) was fabricated to illustrate the subject innovation. A fluorescence solid polyurethane rod containing uniformly dispersed TiO2 and Qdot705 was covered with non-fluorescence solid polyurethane layer with varying thickness. Ph2 was imaged with the OCT-fluorescence catheter at a different position, providing OCT images and fluorescence images of the rod with different depth profiles (
As can be seen in
While the above disclosure describes certain illustrative embodiments, the invention is not limited to the above-described embodiments, and the following claims include various modifications and equivalent arrangements within their scope.
This application claims priority from U.S. Provisional Patent Application No. 62/650,658 filed on Mar. 30, 2018, in the United States Patent and Trademark Office, as well U.S. Provisional Patent Application No. 62/799,516 filed on Jan. 31, 2019, in the United States Patent and Trademark Office, the disclosures of both being incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
5046501 | Crilly | Sep 1991 | A |
5106387 | Kittrell et al. | Apr 1992 | A |
5303026 | Strobl et al. | Apr 1994 | A |
5419323 | Kittrell et al. | May 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5452723 | Wu | Sep 1995 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5697373 | Richards-Kortum et al. | Dec 1997 | A |
6002137 | Hayashi | Dec 1999 | A |
6026319 | Hayashi | Feb 2000 | A |
6070096 | Hayashi | May 2000 | A |
6095982 | Richards-Kortum et al. | Aug 2000 | A |
6317624 | Kollias et al. | Nov 2001 | B1 |
6465968 | Sendai | Oct 2002 | B1 |
6516217 | Tsujita | Feb 2003 | B1 |
6574502 | Hayashi | Jun 2003 | B2 |
6697657 | Shehada et al. | Feb 2004 | B1 |
6763261 | Casscells, III et al. | Jul 2004 | B2 |
6780182 | Bowman et al. | Aug 2004 | B2 |
6800057 | Tsujita et al. | Oct 2004 | B2 |
6869593 | Frangioni | Mar 2005 | B2 |
6915154 | Docherty et al. | Jul 2005 | B1 |
7113814 | Ward et al. | Sep 2006 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7428048 | Farkas et al. | Sep 2008 | B1 |
7447408 | Bouma et al. | Nov 2008 | B2 |
7449153 | Sakai et al. | Nov 2008 | B2 |
7483554 | Kotsianti et al. | Jan 2009 | B2 |
7508524 | Mahadevan-Jansen et al. | Mar 2009 | B2 |
7587236 | Demos et al. | Sep 2009 | B2 |
7749168 | Maschke et al. | Jul 2010 | B2 |
7843572 | Tearney et al. | Nov 2010 | B2 |
7872759 | Tearney et al. | Jan 2011 | B2 |
7877135 | Iketani et al. | Jan 2011 | B2 |
7889348 | Tearney et al. | Feb 2011 | B2 |
7890157 | Jo et al. | Feb 2011 | B2 |
7952706 | Ling et al. | May 2011 | B2 |
7952719 | Brennan, III | May 2011 | B2 |
8035819 | Zuluaga | Oct 2011 | B2 |
8084755 | Hall et al. | Dec 2011 | B2 |
8089625 | Maruc et al. | Jan 2012 | B2 |
8219183 | Maschke et al. | Jul 2012 | B2 |
8289522 | Tearney et al. | Oct 2012 | B2 |
8380268 | Georgakoudi et al. | Feb 2013 | B2 |
8473036 | Gorman, III et al. | Jun 2013 | B2 |
8553219 | Patil et al. | Oct 2013 | B2 |
8571640 | Holman | Oct 2013 | B2 |
8582096 | Chen et al. | Nov 2013 | B2 |
8849380 | Patwardhan | Sep 2014 | B2 |
8928889 | Tearney et al. | Jan 2015 | B2 |
8953911 | Xu et al. | Feb 2015 | B1 |
9087368 | Tearney et al. | Jul 2015 | B2 |
9121926 | Nair et al. | Sep 2015 | B2 |
9179845 | Farcy et al. | Nov 2015 | B2 |
9286673 | Begin et al. | Mar 2016 | B2 |
9326682 | Tearney et al. | May 2016 | B2 |
9332942 | Jaffer et al. | May 2016 | B2 |
9557154 | Tearney et al. | Jan 2017 | B2 |
9795301 | Fleming et al. | Oct 2017 | B2 |
9869828 | Altshuler | Jan 2018 | B2 |
10130259 | Lam et al. | Nov 2018 | B2 |
20040156782 | Alam | Aug 2004 | A1 |
20040241089 | Brister et al. | Dec 2004 | A1 |
20050273267 | Maione | Dec 2005 | A1 |
20070038124 | Fulghum, Jr. et al. | Feb 2007 | A1 |
20070078348 | Holman | Apr 2007 | A1 |
20070158585 | Hall | Jul 2007 | A1 |
20070225579 | Lucassen et al. | Sep 2007 | A1 |
20080103384 | Pfister | May 2008 | A1 |
20080177145 | Furnish | Jul 2008 | A1 |
20080228086 | Ilegbusi et al. | Sep 2008 | A1 |
20080255426 | Iketani | Oct 2008 | A1 |
20090073439 | Tearney et al. | Mar 2009 | A1 |
20090153852 | Rensen | Jun 2009 | A1 |
20090192358 | Jaffer et al. | Jul 2009 | A1 |
20090203991 | Papaioannou et al. | Aug 2009 | A1 |
20090262993 | Kotsianti et al. | Oct 2009 | A1 |
20100092389 | Jaffer | Apr 2010 | A1 |
20100315632 | Brennan, III | Dec 2010 | A1 |
20110237895 | Yoshida et al. | Sep 2011 | A1 |
20110292400 | Fleming et al. | Dec 2011 | A1 |
20120101374 | Tearney et al. | Apr 2012 | A1 |
20130235369 | Koifman | Sep 2013 | A1 |
20140276011 | Schmitt et al. | Sep 2014 | A1 |
20150080686 | Karlheinz et al. | Mar 2015 | A1 |
20150141278 | Hollman-Hewgley | May 2015 | A1 |
20150185151 | Utzinger et al. | Jul 2015 | A1 |
20160228097 | Jaffer et al. | Aug 2016 | A1 |
20170135584 | Tearney et al. | May 2017 | A1 |
20170209049 | Wang et al. | Jul 2017 | A1 |
20180055953 | Jaffer et al. | Mar 2018 | A1 |
20180136129 | Rizo et al. | May 2018 | A1 |
20180348439 | Yamada | Dec 2018 | A1 |
20190059734 | Yamada | Feb 2019 | A1 |
20190391338 | Tearney et al. | Dec 2019 | A1 |
20200085285 | Yamada | Mar 2020 | A1 |
Number | Date | Country |
---|---|---|
2015532179 | Nov 2015 | JP |
2016099253 | May 2016 | JP |
Entry |
---|
Ughi et al. (“Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging”, Int J Cardiovasc Imaging, 31, p. 259-268, 2015) (Year: 2015). |
Ughi, G. J., et al “Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging”, Int J Cardiovasc Imaging, Author Manuscript, Feb. 2015, pp. 1-18, vol. 31, No. 2. |
Koskinas, K. C., et al., “Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment”, European Heart Journal, Dec. 2015, pp. 1-15. |
Vinegoni, C., et al, “Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques”, Sci Transl Med, May 25, 2011, vol. 3, No. 84, pp. 1-20. |
Osborn, E. A., et al, “The Advancing Clinical Impact of Molecular Imaging in CVD”, JACC: Cardiovascular Imaging, Dec. 2013, pp. 1-25, vol. 6, No. 12. |
Lee, S., et al, “Fully Integrated High-Speed Intravascular Optical Coherence Tomography/Near-Infrared Fluorescence Structural/Molecular Imaging In Vivo Using a Clinically Available Near-Infrared Fluorescence- Emitting Indocyanine Green to Detect Inflamed Lipid-Rich Atheromata in Coronary-Sized Vessels”, Circ Cardivasc Interv, 2014, pp. 560-569. |
Hara, T., et al, “Molecular imaging of fibrin deposition in deep vein thrombosis using a new fibrin-targeted near-infrared fluorescence (NIRF) imaging strategy”, JACC Cardiovasc Imaging, Jun. 2012, pp. 1-16, vol. 5, No. 6. |
Jo, J. A., et al, “Simultaneous morphological and biotechnical endogenous optical imaging of atherosclerosis”, European Heart Journal—Cardiovascular Imaging, 2015, pp. 910-918, vol. 16. |
Fard, A. M., et al, “Optical coherence tomography—near infrared spectroscopy system and catheter for intravascular imaging”, Optics Express, Dec. 16, 2013, pp. 30849-30858 vol. 21, No. 25. |
Phipps, J., et al, “Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques”, Joural of Biomedical Optics, Sep. 2011, vol. 16, No. 9, pp. 096018-1-096018-8. |
Scepanovic, O. B., et al, “Multimodal spectroscopy detects features of vulnerable atherosclerotic plaque”, Journal of Biomedical Optics, Jan. 2011, vol. 16, No. 1, pp. 011009-1-011009-10. |
Ughi, G. J., et al, “Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging”, JACC Cardiovascular Imaging, 2016, pp. 1-11. |
Yoo, H., et al, “Intra-arterial catheter for simultaneous microstuctural and molecular imaging in vivo”, Nature Medicine, Dec. 2011, pp. 1680-1685, vol. 17, No. 12. |
Sebastian Dochow, et al., Combined Fiber Probe for Fluorescence Lifetime and Raman Spectroscopy, Author manuscript, Anal Bioanal Chem., PMC, Aug. 23, 2016, pp. 1-20. |
Jessica P. Miller, et al., Noninvasive Depth Estimation Using Tissue Optical Properties and a Dual-Wavelength Fluorescent Molecular Probe in Vivo, Biomedical Optics Express, Jun. 1, 2017, pp. 3095-3109, vol. 8, No. 6. |
Hao Wang, et al., Ex Vivo Catheter-Based Imaging of Coronary Atherosclerosis Using Multimodality OCT and NIRAF Excited at 633 nm, Biomedical Optics Express, Mar. 19, 2015, pp. 1363-1375, vol. 6, No. 4. |
Dinglong MA, et al. Rotational Multispectral Fluorescence Lifetime Imaging and Intravascular Ultrasound: Bimodal System for Intravascular Applications, Journal of Biomedical Optics, vol. 19, Issue 6, Jun. 2014, 12 pages. |
AJ Dixon, et al., Intravascular near-infrared fluorescence catheter with ultrasound guidance and blood attenuation correction. Journal of Biomedical Optics, May 2013, vol. 18, No. 5, 11 pages. |
Shengnan Liu, et al., Analysis and compensation for the effect of the catheter position on image intensities in intravascular optical coherence tomography, Journal of Biomedical Optics, Dec. 2016, vol. 21, No. 12, 10 pages. |
Loretta Scolaro, et al., “Molecular Imaging Needles: Dual-Modality Optical Coherence Tomography and Fluorescence Imaging of Labeled Antibodies Deep in Tissue”, Biomedical Optics Express, Optical Society of America, vol. 6, No. 5, May 2015, pp. 1767-1781. |
Wang, H., “Near infrared autofluorescence augmentation of optical coherence tomography for diagnosis of coronary atherosclerosis”, Thesis/Dissertation, Boston University College of Engineering, 2014, 251 pages. |
Number | Date | Country | |
---|---|---|---|
20190298174 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
62650658 | Mar 2018 | US | |
62799516 | Jan 2019 | US |